Tag: Valneva

Valneva shares are experiencing extreme volatility as the biotech firm navigates conflicting developments. While a major refinancing deal has resolved ...

Investors in Valneva are navigating turbulent waters as the biotechnology firm delivers a dual announcement: significantly reduced annual projections coupled ...

The French vaccine developer Valneva finds itself at a pivotal moment, with its future prospects increasingly tied to the success ...

Investors are celebrating a major turnaround for Valneva as the biopharmaceutical company released compelling long-term results for its Chikungunya vaccine ...

Valneva SA has encountered a significant regulatory obstacle as US health authorities suspended all distribution and sales of its recently ...

French biotechnology firm Valneva has encountered a severe regulatory obstacle following the US Food and Drug Administration's (FDA) immediate suspension ...

French vaccine developer Valneva faces a significant crisis after US regulators delivered a stunning blow. The Food and Drug Administration ...

Investors in French vaccine developer Valneva have experienced a period of extreme volatility, witnessing both significant setbacks and encouraging developments ...

The French vaccine developer Valneva faces a severe crisis following an unexpected regulatory decision from the United States. The Food ...